Biocon Market Cap

Biocon has a market cap or net worth of 404.76 billion as of May 14, 2025. Its market cap has increased by 21.01% in one year.

Market Cap

404.76B

Enterprise Value

603.39B

Revenue

164.70B

Ranking

n/a

PE Ratio

39.98

Stock Price

338.20

Market Cap Chart

Since April 7, 2004, Biocon's market cap has increased from 45.41B to 404.76B, an increase of 791.29%. That is a compound annual growth rate of 10.92%.

Market Cap History

Date	Market Cap	% Change
May 13, 2025	394.77B	-9.72%
Dec 31, 2024	437.25B	46.69%
Dec 29, 2023	298.08B	-4.59%
Dec 30, 2022	312.41B	-27.97%
Dec 31, 2021	433.73B	-21.37%
Dec 31, 2020	551.59B	58.78%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	4,186.36B
Divi's Laboratories	1,599.58B
Cipla	1,195.31B
Mankind Pharma	993.57B
Apollo Hospitals Enterprise	966.52B
Zydus Lifesciences	884.13B
Aurobindo Pharma	676.29B
Alkem Laboratories	591.43B

Market Cap Rankings